NM
Nesrin Mogulkoc
EGE UNIVERSITY HOSPITAL
Research areas: Medicine · Pulmonary and Respiratory Medicine · Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis · Chronic Obstructive Pulmonary Disease (COPD) Research · Pulmonary Hypertension Research and Treatments
0000-0003-1870-5669
Employment
-
EGE UNIVERSITY HOSPITAL PROFESSOR2002 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (140)
- Pulmonary Alveolar Proteinosis in Greece–Türkiye–Cyprus: Answers in a Real‐Life Comparison Save
- Rare biallelic loss-of-function variants in the LRRK2 kinase cause interstitial lung disease Save
- Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis Save
- Childhood interstitial lung disease survivors in adulthood: a European collaborative study Save
- Identifying outcome domains to establish a core outcome set for progressive pulmonary fibrosis: a scoping review Save
- Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis Save
- RISK FACTORS AND MANAGEMENT OF LUNG CANCER IN IDIOPATHIC PULMONARY FIBROSIS: A COMPREHENSIVE REVIEW Save
- Tube2FEM: a general-purpose highly automated pipeline for flow-related processes in (embedded) tubular objects Save
- İdiyopatik Pulmoner Fibroziste Seri Solunum Fonksiyon Testlerinin Prognozu Belirlemedeki Önemi "Retrospektif Analiz'' Save
- Children's ILDs survivors in adulthood: a European Study Save
- Diagnosis and Treatment Patterns of Chronic Thromboembolic Pulmonary Hypertension in Russia, Kazakhstan, Turkey, Lebanon, and Saudi Arabia: A Registry Study Save
- Does Metformin Influence Clinically Relevant Outcomes in IPF? Save
- Good health' for patients with PPF: Insights from patient-led international focus groups Save
- Health outcomes in IPF and PPF: European survey on healthcare professionals' views and practices Save
- Identifying outcome domains to establish a core outcome set for progressive pulmonary fibrosis: a scoping review Save
- Interpolation-split: a data-centric deep learning approach with big interpolated data to boost airway segmentation performance Save
- LUNG CANCER IN PATIENTS WITH PULMONARY FIBROSIS: CHARACTERISTICS FEATURES AND PROGNOSIS Save
- Mortality surrogates in combined pulmonary fibrosis and emphysema Save
- Multicenter real-world data of antifibrotics in non-IPF progressive pulmonary fibrosis (PPF) patients Save
- RESOLVE-LUNG, a multinational, randomized, placebo-controlled Phase II trial of namilumab, an anti-GMCSF monoclonal antibody, in chronic pulmonary sarcoidosis: trial and characteristics Save